Last $59.05 USD
Change Today -0.61 / -1.02%
Volume 1.0M
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

dexcom inc (DXCM) Snapshot

Open
$59.63
Previous Close
$59.66
Day High
$59.73
Day Low
$57.44
52 Week High
02/23/15 - $64.64
52 Week Low
05/2/14 - $28.09
Market Cap
4.6B
Average Volume 10 Days
659.5K
EPS TTM
$-0.30
Shares Outstanding
77.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DEXCOM INC (DXCM)

dexcom inc (DXCM) Related Businessweek News

No Related Businessweek News Found

dexcom inc (DXCM) Details

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 system, a continuous glucose monitoring system; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. DexCom, Inc. markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.

838 Employees
Last Reported Date: 02/25/15
Founded in 1999

dexcom inc (DXCM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $325.0K
Executive Chairman
Total Annual Compensation: $420.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $237.0K
Chief Technical Officer
Total Annual Compensation: $284.9K
Executive Vice President of Strategy & Corpor...
Total Annual Compensation: $284.9K
Compensation as of Fiscal Year 2013.

dexcom inc (DXCM) Key Developments

DexCom, Inc. Provides Product Revenue Guidance for the Year 2015

DexCom, Inc. provided product revenue guidance for the year 2015 of between $340 million and $360 million.

DexCom, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

DexCom, Inc. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenue of $84.3 million compared to $51.7 million a year ago. Operating income was $1.6 million compared to operating loss of $2.3 million a year ago. Income before income taxes was $1.4 million compared to loss before income taxes of $2.6 million a year ago. Net income was $1.3 million or $0.02 per diluted share compared to net loss of $2.6 million or $0.04 per basic and diluted share a year ago. For the year, the company reported total revenue of $259.2 million compared to $160 million a year ago. Operating loss was $21.5 million compared to $28.9 million a year ago. Loss before income taxes was $22.3 million compared to $29.8 million a year ago. Net loss was $22.4 million or $0.30 per basic and diluted share compared to $29.8 million or $0.42 per basic and diluted share a year ago.

DexCom, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:15 AM

DexCom, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:15 AM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Steven R. Pacelli, Executive Vice President of Strategy & Corporate Development.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $59.05 USD -0.61

DXCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Insulet Corp $31.37 USD -1.14
Merge Healthcare Inc $4.49 USD +0.32
NeuStar Inc $25.13 USD +0.06
Radview Software Ltd $0.0016 USD 0.00
Tandem Diabetes Care Inc $12.41 USD +0.06
View Industry Companies
 

Industry Analysis

DXCM

Industry Average

Valuation DXCM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.7x
Price/Book 32.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit www.dexcom.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.